Market Value137,477,000
Total Holdings60
File Date2022-08-12
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
XENE / Xenon Pharmaceuticals Inc.
GTHX / G1 Therapeutics, Inc.
IMGN / ImmunoGen, Inc.
SILK / Silk Road Medical, Inc
PXD / Pioneer Natural Resources Company
TSVT / 2seventy bio, Inc.
GOSS / Gossamer Bio, Inc.
ARVN / Arvinas, Inc.
STOK / Stoke Therapeutics, Inc.
NBIX / Neurocrine Biosciences, Inc.
ALKS / Alkermes plc
BHVN / Biohaven Ltd.
KPTI / Karyopharm Therapeutics Inc.
CNCE / Concert Pharmaceuticals Inc
OVV / Ovintiv Inc.
CLR / Continental Resources Inc (OKLA)
NKTR / Nektar Therapeutics
ISEE / IVERIC bio Inc
ZNTL / Zentalis Pharmaceuticals, Inc.
BLUE / bluebird bio, Inc.
AKBA / Akebia Therapeutics, Inc.
AWH / Aspira Women's Health Inc.
TPTX / Turning Point Therapeutics Inc
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
BIIB / Biogen Inc.
FHTX / Foghorn Therapeutics Inc.
PTGX / Protagonist Therapeutics, Inc.
KALV / KalVista Pharmaceuticals, Inc.
BDSX / Biodesix, Inc.
BMY / Bristol-Myers Squibb Company
VTYX / Ventyx Biosciences, Inc.
CYTK / Cytokinetics, Incorporated
LSF / Laird Superfood, Inc.
VNDA / Vanda Pharmaceuticals Inc.
IRTC / iRhythm Technologies, Inc.
NARI / Inari Medical, Inc.
ALBO / Albireo Pharma Inc
INBX.V / Inhibrx, Inc.
CFRX / ContraFect Corp
CGEM / Cullinan Therapeutics, Inc.
MASI / Masimo Corporation
APLS / Apellis Pharmaceuticals, Inc.
ACAD / ACADIA Pharmaceuticals Inc.
ELUT / Elutia Inc.
PHR / Phreesia, Inc.
BCRX / BioCryst Pharmaceuticals, Inc.
DCGO / DocGo Inc.
CORT / Corcept Therapeutics Incorporated
ANGN / Angion Biomedica Corp
CCXI / ChemoCentryx Inc
AVEO / AVEO Pharmaceuticals Inc
SIEN / Sientra, Inc.
SLNO / Soleno Therapeutics, Inc.
QDEL / QuidelOrtho Corporation
IFRX / InflaRx N.V.
YTEN / Yield10 Bioscience, Inc.
AXDX / Accelerate Diagnostics, Inc.
UTHR / United Therapeutics Corporation
PRTA / Prothena Corporation plc
HROW / Harrow, Inc.
FOLD / Amicus Therapeutics, Inc.
KNSA / Kiniksa Pharmaceuticals, Ltd.
ETRN / Equitrans Midstream Corporation
XNCR / Xencor, Inc.